Clinilabs Drug Development Corporation — New York, New York

Clinilabs Drug Development Corporation is a clinical research site located in New York, New York, United States 10019.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Clinilabs Drug Development Corporation has participated in 7 clinical trials with 1 currently active.

Therapeutic areas: Transient Insomnia, Obstructive Sleep Apnea, Healthy Volunteers.

Sponsors: Sequential Medicine Ltd, Apnimed, Takeda.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinilabs Drug Development Corporation?

Clinilabs Drug Development Corporation has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinilabs Drug Development Corporation conducted?

Clinilabs Drug Development Corporation has 7 clinical trials on record, with 1 currently active. Their work covers Transient Insomnia, Obstructive Sleep Apnea, Healthy Volunteers.

Is Clinilabs Drug Development Corporation accredited by Crixeo Health?

Yes — Clinilabs Drug Development Corporation holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Clinilabs Drug Development Corporation?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.